Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study

QR Code

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study

Purpose: Although aspirin therapy is used widely in older adults for prevention of cardiovascular disease, its impact on the incidence, progression and severity of age-related macular degeneration (AMD) is uncertain. The effect of low-dose aspirin on the course of AMD will be evaluated in this clini...

Full description

Bibliographic Details
Main Authors:	Robman, L., Guymer, R., Woods, R., Ward, S., Wolfe, R., Phung, J., Hodgson, L., Makeyeva, G., Aung, K., Gilbert, T., Lockery, J., Le-Pham, Y., Orchard, S., Storey, E., Abhayaratna, W., Reid, D., Ernst, M., Nelson, M., Reid, Christopher, McNeil, J.
Format:	Journal Article
Published:	2017
Online Access:	http://hdl.handle.net/20.500.11937/53523

Similar Items

ASPREE-D: Aspirin for the prevention of depression in the elderly
by: Berk, M., et al.
Published: (2016)

Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2019)

Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2017)

Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial
by: Lowthian, J., et al.
Published: (2016)

Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors
by: Stocks, N., et al.
Published: (2018)

Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly (ASPREE) study cohort
by: Polkinghorne, K., et al.
Published: (2019)

The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study
by: Ward, S., et al.
Published: (2018)

Overcoming challenges to data quality in the ASPREE clinical trial
by: Lockery, J.E., et al.
Published: (2019)

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
by: Grimm, R., et al.
Published: (2013)

Aspirin for the prevention of cognitive decline in the elderly: Rationale and design of a neuro-vascular imaging study (ENVIS-ion)
by: Reid, Christopher, et al.
Published: (2012)

Intravitreal therapy in bilateral neovascular age-related macular degeneration
by: Barthelmes, D., et al.
Published: (2014)

Quality of life in patients with neovascular age related macular degeneration (n-AMD) seen in a public hospital of Malaysia
by: Rituparna Ghoshal,, et al.
Published: (2018)

Effect of aspirin on disability-free survival in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

The aspirin in reducing events in the elderly trial: Statistical analysis plan
by: Wolfe, R., et al.
Published: (2018)

Effect of aspirin on all-cause mortality in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

Two-Year Outcomes of "Treat and Extend" Intravitreal Therapy for Neovascular Age-Related Macular Degeneration
by: Arnold, J., et al.
Published: (2014)

Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naïve eyes
by: Gillies, M., et al.
Published: (2013)

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort
by: Gillies, M., et al.
Published: (2014)

A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data
by: Neumann, J.T., et al.
Published: (2022)

Nutrients for prevention of macular degeneration and eye-related diseases
by: Khoo, Hock Eng, et al.
Published: (2019)

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
by: Ryan, Joanne, et al.
Published: (2020)

Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial
by: Berk, M., et al.
Published: (2020)

The effect of normal aging and age-related macular degeneration on perceptual learning
by: Astle, Andrew T., et al.
Published: (2015)

Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial
by: Islam, R.M., et al.
Published: (2022)

The role of lipid toxicity and para-inflammation as potential mechanisms of age related macular degeneration
by: Al-Rashed, Fatema
Published: (2016)

Self-management education programs for age-related macular degeneration: A systematic review
by: Lee, L., et al.
Published: (2008)

Evaluation of tears oxidative stress markers in Malay age-related macular degeneration patients
by: Ni, Koh Yi
Published: (2018)

Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration.
by: Saleh, Rafidah, et al.
Published: (2017)

Genetic variation in PEAR1, cardiovascular outcomes and effects of aspirin in a healthy elderly population
by: Lewis, J.P., et al.
Published: (2020)

Effect of aspirin on cancer incidence and mortality in older adults.
by: McNeil, John J, et al.
Published: (2020)

Long-Term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with Ranibizumab
by: Menke, Marcel N., et al.
Published: (2013)

Vitrectomy for breakthrough bleeding in age related macular degeneration and polypoidal choroidal vasculopathy in a Malaysian hospital
by: Bastion, MLC, et al.
Published: (2012)

Prevalence and genetic analyses of selected age-related macular degeneration-related polymorphisms and their responses to intravitreal ranibizumab
by: Mohamad, Nur Afiqah
Published: (2018)

Normative performance of healthy older individuals on the Modified Mini-Mental State (3MS) examination according to ethno-racial group, gender, age, and education level
by: Ryan, J., et al.
Published: (2018)

DAMA madahka finalis AMD
by: Utusan, Sarawak
Published: (2012)

Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study)
by: Sharman, J., et al.
Published: (2017)

Pencalonan AMD 2012 minggu ini
by: Utusan, Sarawak
Published: (2012)

AMD 2012 grand finale this Saturday
by: New Sarawak, Tribune
Published: (2012)

Biokinetic test for the characterisation of AMD generation potential of sulfide mineral wastes
by: Hesketh, A.H., et al.
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f4s113tduknu9n1kfb7jv2jgjk